"The second payment of RMB2.5 Million (approximately USD$390,000) will be made upon receipt of the third party valuation expected this month. Upon receipt of the third party valuation, the Company's Board will review and if the transaction is approved by the Board, the Board shall seek approval of the matter at the Company's Annual Meeting of Stockholders, the date of which is to be determined"
FDA was WRONG again!!! The "biggest SDRG PR ever" will have to wait later but not this week!! Sooo this thing has been going for a year now and they are still waiting for the 3rd party evaluation?!? Is this a joke??
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.